V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280010090 | 280005298 | 1.57 | null | Curative (C) | 2013-10-07 | 2013-10-07 | Cisplatin | 02 | N | 280026152 | CISPLATIN |
| 280010091 | 280005300 | 1.7 | 57.4 | Palliative (P) | 2017-01-27 | 2017-02-22 | Cetuximab + Radiotherapy Load | null | null | 280026163 | CETUXIMAB + RT |
| 280010092 | 280008795 | null | 55 | Palliative (P) | 2017-03-25 | 2017-03-26 | Doxorubicin 75mg/m2 | N | N | 280026163 | DOXORUBICIN |
| 280010093 | 280005302 | 1.62 | 43 | Curative (C) | 2013-06-22 | 2013-06-28 | Cisplatin | null | null | 280026175 | CISPLATIN |
| 280010094 | 280005303 | null | null | Palliative (P) | 2014-07-22 | 2014-07-26 | DOXORUBICIN | null | N | 280026178 | DOXORUBICIN |
| 280010095 | 280005304 | 1.6 | 48.8 | null | 2016-06-11 | 2016-08-23 | Cisplatin | null | null | 280026183 | CISPLATIN |
| 280010096 | 280005305 | 1.58 | 39.85 | Disease modification (D) | 2018-10-04 | 2018-11-16 | STS Rhabdomyosarcoma RMS 2005 IVADo | null | null | 280026192 | RMS 2005 TRIAL |
| 280010097 | 280010477 | 1.55 | 64 | null | 2017-07-23 | 2017-07-24 | Cisplatin 7 day | 02 | N | 280026195 | CISPLATIN |
| 280010098 | 280005310 | 1.9 | null | Curative (C) | 2015-09-16 | 2016-02-24 | Cetuximab + Radiotherapy Maint | N | Y | 280026205 | CETUXIMAB + RT |
| 280010099 | 280005312 | 1.75 | 93.2 | Curative (C) | 2016-11-18 | 2016-11-18 | CARBOPLATIN + RT | 02 | Y | 280026209 | CARBOPLATIN + RT |
| 280010100 | 280005312 | 1.56 | 75 | Palliative (P) | 2015-08-13 | 2015-08-13 | Ifosfamide | N | null | 280026209 | IFOSFAMIDE |
| 280010101 | 280005313 | null | 58 | Curative (C) | 2013-08-04 | 2013-09-01 | CETUXIMAB + RT | N | Y | 280026220 | CETUXIMAB + RT |
| 280010102 | 280005315 | 1.72 | 71.8 | Palliative (P) | 2018-09-12 | 2018-09-18 | Paclitaxel 7 day | 2 | N | 280026221 | PACLITAXEL |
| 280010103 | 280005316 | 1.63 | 47.3 | Neo-adjuvant (N) | null | 2014-06-25 | Cisplatin | N | Y | 280026223 | CISPLATIN |
| 280010104 | 280005319 | 1.88 | 98 | Palliative (P) | 2017-12-15 | 2018-01-11 | Cisplatin | Y | N | 280026228 | CISPLATIN |
| 280010105 | 280005321 | 1.85 | 90 | Palliative (P) | 2015-01-14 | 2015-01-16 | Doxorubicin 75mg/m2 | 02 | N | 280026231 | DOXORUBICIN |
| 280010106 | 280005324 | null | null | null | 2014-12-28 | 2014-12-28 | Cisplatin | N | N | 280026243 | CISPLATIN |
| 280010107 | 280005326 | 1.95 | 80.2 | Palliative (P) | 2017-01-31 | 2017-01-31 | Ifosfamide | N | N | 280026247 | IFOSFAMIDE |
| 280010108 | 280005329 | 1.65 | 88 | Adjuvant (A) | null | 2015-10-03 | CETUXIMAB + RT | null | null | 280026255 | CETUXIMAB + RT |
| 280010109 | 280005330 | 1.74 | 70 | Palliative (P) | 2014-03-03 | 2014-04-07 | Cetuximab + Radiotherapy Maint | null | null | 280026256 | CETUXIMAB + RT |
| 280010110 | 280005332 | null | 84.6 | Palliative (P) | 2015-03-13 | 2015-03-13 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | 280026259 | IVA |
| 280010111 | 280010480 | null | 72.6 | Palliative (P) | 2014-09-17 | 2014-10-30 | CETUXIMAB + RT | N | null | 280026263 | CETUXIMAB + RT |
| 280010112 | 280005333 | 0 | 53.4 | Palliative (P) | 2014-11-21 | 2015-11-07 | STS Rhabdo RMS 2005 Vin Cyclo | null | null | 280026267 | RMS 2005 TRIAL |
| 280010113 | 280005335 | 1.53 | 79.5 | Curative (C) | null | 2014-03-20 | CARBOPLATIN + RT | Y | N | 280026275 | CARBOPLATIN + RT |
| 280010114 | 280005337 | 0 | 71.3 | Palliative (P) | 2015-02-03 | 2015-02-07 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | N | 280026282 | RMS 2005 TRIAL |
| 280010115 | 280005339 | 1.85 | 120 | Palliative (P) | 2017-07-31 | 2017-12-23 | Paclitaxel 7 day | N | N | 280026292 | PACLITAXEL |
| 280010116 | 280011302 | 1.6 | 51.9 | Curative (C) | 2013-11-14 | 2013-11-26 | CETUXIMAB + RT | 02 | Y | 280026301 | CETUXIMAB + RT |
| 280010117 | 280005340 | 1.8 | 94.2 | Curative (C) | 2014-04-09 | 2014-10-28 | Ifosfamide PVI 1g/m2 14day | N | N | 280026309 | IFOSFAMIDE |
| 280010118 | 280005344 | 1.66 | 50.5 | Palliative (P) | 2017-07-10 | 2017-09-05 | Doxorubicin 75mg/m2 | 02 | N | 280026313 | DOXORUBICIN |
| 280010119 | 280005349 | 1.65 | 45.5 | Palliative (P) | 2016-02-02 | 2016-02-02 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 280026319 | PACLITAXEL |
| 280010120 | 280008817 | 1.57 | 60.3 | Palliative (P) | 2014-09-29 | 2014-10-16 | DOXORUBICIN | null | null | 280026333 | DOXORUBICIN |
| 280010121 | 280005355 | null | 65.55 | Curative (C) | 2017-09-03 | 2017-09-04 | CARBOPLATIN + RT | null | null | 280026342 | CARBOPLATIN + RT |
| 280010122 | 280008818 | 0 | null | Neo-adjuvant (N) | 2018-02-11 | 2018-02-15 | STS Rhabdomyosarcoma RMS 2005 IVADo | N | N | 280026344 | RMS 2005 TRIAL |
| 280010123 | 280005358 | 1.58 | 49 | Curative (C) | 2018-06-27 | 2018-08-15 | Cisplatin | N | Y | 280026347 | CISPLATIN |
| 280010124 | 280008819 | 1.54 | 70.9 | Palliative (P) | 2018-06-02 | 2018-06-04 | Paclitaxel 7 day | N | N | 280026352 | PACLITAXEL |
| 280010125 | 280008820 | 1.65 | 85.1 | Palliative (P) | 2014-11-12 | 2014-11-24 | Paclitaxel 7 day | N | N | 280026361 | PACLITAXEL |
| 280010126 | 280005365 | 1.76 | null | Palliative (P) | 2013-08-28 | 2013-09-02 | Paclitaxel 80mg/m2 day 1 8 15 | null | null | 280026376 | PACLITAXEL |
| 280010127 | 280005366 | 1.7 | 14.9 | Palliative (P) | 2014-01-14 | 2014-02-24 | Ifosfamide | N | N | 280026385 | IFOSFAMIDE |
| 280010128 | 280008823 | null | 38.1 | Curative (C) | 2014-05-08 | 2014-05-09 | CARBOPLATIN + RT | N | N | 280026386 | CARBOPLATIN + RT |
| 280010129 | 280005367 | 1.6 | 80.6 | Adjuvant (A) | 2016-03-07 | 2016-03-08 | Doxorubin 50mg/m2 | N | N | 280026392 | DOXORUBICIN |
| 280010130 | 280005371 | 1.61 | 25.5 | Palliative (P) | null | 2015-11-16 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 280026402 | PACLITAXEL |
| 280010131 | 280005373 | 1.58 | null | Palliative (P) | 2016-09-20 | 2016-10-05 | Cetuximab + Radiotherapy Maint | 02 | N | 280026417 | CETUXIMAB + RT |
| 280010132 | 280010491 | null | 64.8 | Curative (C) | 2017-09-05 | 2017-09-20 | Cisplatin | Y | N | 280026419 | CISPLATIN |
| 280010133 | 280005374 | 1.7 | 55 | Adjuvant (A) | 2016-06-20 | 2016-09-05 | Cisplatin | N | Y | 280026440 | CISPLATIN |
| 280010134 | 280005376 | null | 108.8 | Neo-adjuvant (N) | 2015-12-29 | 2016-01-02 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | N | 280026462 | RMS 2005 TRIAL |
| 280010135 | 280005381 | 1.28 | null | null | 2015-04-13 | 2015-05-29 | STS Rhabdo RMS 2005 Vin Cyclo | Y | N | 280026482 | RMS 2005 TRIAL |
| 280010136 | 280005383 | 1.74 | 81 | Palliative (P) | 2017-06-15 | 2017-06-23 | Ifosfamide | N | N | 280026486 | IFOSFAMIDE |
| 280010137 | 280005384 | 1.6 | 57.2 | Neo-adjuvant (N) | 2017-07-09 | 2017-09-01 | Cetuximab + Radiotherapy Maint | N | N | 280026513 | CETUXIMAB + RT |
| 280010138 | 280005385 | 1.74 | 50.2 | Neo-adjuvant (N) | 2016-09-14 | 2017-08-30 | Ifosfamide | N | N | 280026519 | IFOSFAMIDE |
| 280010139 | 280005386 | null | null | Adjuvant (A) | 2017-02-16 | 2017-02-16 | CARBOPLATIN + RT | N | N | 280026521 | CARBOPLATIN + RT |